Japanese drugmaker Otsuka Pharmaceutical has announced that the European Medicines Agency (EMA) has accepted for review the ...

Anthem Biosciences files for a $397 million IPO amid India’s record-breaking year for public listings. The Bengaluru-based ...

Alon Natanson, a business leader and alumnus of the Hebrew University of Jerusalem, has been appointed chief executive ...

Santhera partners with Clinigen to supply Agamree for Duchenne muscular dystrophy in regions without commercial availability.

China’s National Medical Products Administration (NMPA) has approved the second New Drug Application (NDA) of Dovbleron ...

Californian biotech General Proximity announced its emergence from stealth on Friday, unveiling its proprietary OmniTAC ...